berberine has been researched along with cyclin d1 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M; Mizukami, H; Suzuki, H; Tanabe, H | 1 |
| Deng, WW; Hao, Y; Li, N; Luo, Y; Shi, TP | 1 |
| Chen, CY; Hsu, SL; Hsueh, CM; Liang, KW; Lin, SJ; Ting, CT; Yin, SC | 1 |
| Chai, YS; Du, F; Du, LJ; Hu, J; Lei, F; Lu, X; Wang, XP; Wang, YG; Xing, DM; Yuan, ZY; Zhang, D | 1 |
| Colburn, NH; Hou, W; Hua, B; Jia, L; Li, W; Lin, H; Matter, MS; Saud, SM; Young, MR | 1 |
| Cao, LL; Du, Y; Gu, B; Hou, T; Li, M; Liu, X; Lu, X; Shen, C; Song, B; Wang, D; Wang, H; Wang, L; Wei, FZ; Yang, Q; Yang, Y; Zhao, Y; Zhu, Q; Zhu, WG | 1 |
| Fu, L; Wen, C; Wu, L; Zhang, X; Zhou, H | 1 |
| Deng, M; He, B; Li, Y; Liu, S; Tao, H; Xia, S; Zhang, C; Zhou, Y | 1 |
| Feng, Y; Li, S; Tan, HY; Tsang, CM; Tsao, SW; Wang, N; Wang, X | 1 |
| Boonmars, T; Cha'on, U; Phoomak, C; Puthdee, N; Seubwai, W; Vaeteewoottacharn, K; Wongkham, S | 1 |
| Han, B; Huang, T; Li, X; Li, Z; Ma, H; Tian, C; Wang, M; Xiao, Y; Ye, X | 1 |
| Guan, L; Lai, M; Li, J; Wang, H; Wen, X | 1 |
| Nakamura, S; Nihashi, Y; Shinji, S; Takaya, T; Umezawa, K | 1 |
| Li, D; Ren, M; Su, X; Su, Y; Yang, L | 1 |
| Gao, X; Hong, T; Wang, Y; Zhang, C; Zhang, J; Zhang, P | 1 |
| Ai, M; Kong, L; Li, J; Ni, L; Sun, P; Xu, R | 1 |
16 other study(ies) available for berberine and cyclin d1
| Article | Year |
|---|---|
Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Base Sequence; Berberine; Cell Cycle; Cyclin D1; Cyclin G; Cyclin G1; Cyclins; DNA Primers; DNA Replication; Hydrolysis; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tubulin | 2005 |
Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
Topics: Amino Acid Motifs; Antineoplastic Agents; Berberine; Carcinoma, Giant Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Genes, Reporter; Humans; Luciferases; Lung Neoplasms; Time Factors; Transcription Factor AP-1; Transfection | 2008 |
Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Cell Movement; Cell Proliferation; Cyclin D1; Cyclin D3; Cyclins; MAP Kinase Kinase 1; Multienzyme Complexes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley | 2008 |
Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt.
Topics: Animals; Berberine; Brain Ischemia; Cell Cycle Checkpoints; Cell Survival; Cells, Cultured; Cyclin D1; Hippocampus; Male; Mice; Mice, Inbred ICR; Neurons; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Tumor Suppressor Protein p53 | 2013 |
Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Azoxymethane; Berberine; Carcinogenesis; Caspase 3; Cell Line, Tumor; Colon; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; eIF-2 Kinase; Female; HCT116 Cells; Humans; Mice; NF-kappa B; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2015 |
SET7/9 regulates cancer cell proliferation by influencing β-catenin stability.
Topics: Berberine; beta Catenin; Blotting, Western; Cell Proliferation; Cyclin D1; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HEK293 Cells; HeLa Cells; Histone-Lysine N-Methyltransferase; Humans; Hydrogen Peroxide; Methylation; Mutation; Oxidants; Protein Binding; Protein Stability; Proto-Oncogene Proteins c-myc; RNA Interference; Wnt Signaling Pathway | 2015 |
Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; bcl-2-Associated X Protein; Berberine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2; Tamoxifen | 2016 |
Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway.
Topics: Animals; Berberine; Cartilage, Articular; Cell Cycle; Cell Proliferation; Chondrocytes; Cyclin D1; Cytoskeleton; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3 beta; Lymphoid Enhancer-Binding Factor 1; Nitroprusside; Osteoarthritis; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Transcription Factor 4; Transcription Factors; Wnt Signaling Pathway | 2016 |
Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents, Phytogenic; Berberine; beta-Transducin Repeat-Containing Proteins; Carcinoma, Hepatocellular; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; RNA, Small Interfering; Signal Transduction; Ubiquitin; Xenograft Model Antitumor Assays | 2016 |
Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways.
Topics: Antineoplastic Agents; Berberine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cyclin D1; Cyclin E; Humans; MAP Kinase Signaling System; NF-kappa B; STAT3 Transcription Factor | 2017 |
8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Biomarkers, Tumor; Body Weight; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
The Effects of Berberine on the Gut Microbiota in Apc
Topics: Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Bacteria; Berberine; beta Catenin; Colorectal Neoplasms; Cyclin D1; Diet, High-Fat; DNA, Bacterial; DNA, Ribosomal; Gastrointestinal Microbiome; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Male; Mice; Neoplasms, Experimental; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Xenograft Model Antitumor Assays | 2018 |
Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells.
Topics: Antineoplastic Agents; Berberine; Berberine Alkaloids; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p57; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; G1 Phase Cell Cycle Checkpoints; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Molecular Conformation; Molecular Docking Simulation; Phellodendron; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal | 2020 |
Cell Cycle Regulation by Berberine in Human Melanoma A375 Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin A; Cyclin D1; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Melanocytes; MicroRNAs; Signal Transduction | 2020 |
Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Berberine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cisplatin; Cyclin D1; Cyclin-Dependent Kinase 4; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2 | 2021 |
Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Berberine; beta Catenin; Cadherins; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Cyclin D1; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Lung; Mice; Repressor Proteins | 2022 |